Istituto Oncologico Veneto Irccs

This study tests whether giving the immunotherapy drug pembrolizumab along with standard chemotherapy before surgery can improve outcomes for people with a rare cancer called pleural mesothelioma. About 41 adults with early-stage, treatable mesothelioma will receive the drug comb…

This study looks at how well a combination of three drugs (capecitabine, oxaliplatin, and bevacizumab) works as a first treatment for elderly patients (70 and older) with metastatic colorectal cancer that cannot be removed by surgery. The goal is to see how long the cancer stays …

This study evaluates a new, highly sensitive blood test (Plasma-SeqSensei™) that looks for EGFR gene mutations in lung cancer patients. Researchers will compare it to a standard test to see if it finds more mutations. About 130 adults with advanced non-small cell lung cancer will…

This study tests whether using virtual reality (VR) goggles during the placement of a thin tube (PICC line) can reduce anxiety and pain in cancer patients. About 120 adults will be randomly assigned to either receive VR plus standard care or standard care alone. The goal is to se…

This study looks at how the immune system is weakened in people with aggressive brain tumors called gliomas. Researchers will use special MRI scans and tissue samples to see how certain immune cells behave. The goal is to find new ways to measure immune suppression, which could h…

This study looks at how robotic surgery for prostate, bladder, or kidney cancer affects patients' finances. About 120 adults who had surgery in the last year will fill out questionnaires about money worries, medical costs, and travel expenses. The goal is to understand which pati…

This study looks at whether a short, 8-question screening tool called the G8 can help predict survival and severe side effects from treatment in people aged 70 and older with metastatic colorectal cancer. Researchers will also test a physical performance measure called Timed Up a…